<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02352623</url>
  </required_header>
  <id_info>
    <org_study_id>H-4-2014-127</org_study_id>
    <nct_id>NCT02352623</nct_id>
  </id_info>
  <brief_title>Quality of Life and Surgical Late Effects of Melanoma Treatment</brief_title>
  <official_title>Quality of Life and Surgical Late Effects of Melanoma Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Herlev Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Danish Cancer Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Herlev Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Health-related Quality of life in Danish stage IB-III cutaneous melanoma patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the PhD-study is to evaluate, in a large cohort of Danish melanoma patients:

        1. Health-related quality of life assessing psychological, physical and social well-being

        2. Physical long term side effects (lymphoedema, scarring and neuropathic pain)

        3. Lymphoedema assessed by clinical examination and DXA scans
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Global Health Score</measure>
    <time_frame>12 months</time_frame>
    <description>Quality of life will be assessed with the questionnaire EORTC QLQ-C30 v.3.0</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anxiety</measure>
    <time_frame>12 months</time_frame>
    <description>Anxiety will be assessed with the questionnaire Hospital Anxiety and Depression Scale (HADS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>12 months</time_frame>
    <description>Depression will be assessed with the questionnaire Hospital Anxiety and Depression Scale (HADS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lymphoedema</measure>
    <time_frame>12 months</time_frame>
    <description>Lymphoedema will be assessed with a questionnaire including the LYMQOL questionnaire, clinical examination and DXA scan</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neuropathic pain</measure>
    <time_frame>12 months</time_frame>
    <description>Neuropathic pain will be assessed with a questionnaire including painDetect</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume and tissue composition assessed with DXA scan</measure>
    <time_frame>12 months</time_frame>
    <description>DXA scan</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">435</enrollment>
  <condition>Melanoma</condition>
  <condition>Quality of Life</condition>
  <condition>Lymphedema</condition>
  <condition>Depression</condition>
  <condition>Anxiety</condition>
  <condition>Pain</condition>
  <condition>Cicatrix</condition>
  <arm_group>
    <arm_group_label>Cutaneous melanoma AJCC stage IB-III</arm_group_label>
    <description>Patients treated for cutaneous melanoma (AJCC stage IB-III) will fill out a questionnaire, undergo clinical examination and DXA scan</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>DXA scan</intervention_name>
    <description>DXA scan</description>
    <arm_group_label>Cutaneous melanoma AJCC stage IB-III</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Clinical examination</intervention_name>
    <description>Clinical examination</description>
    <arm_group_label>Cutaneous melanoma AJCC stage IB-III</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients treated for cutaneous melanoma (AJCC stage IB-III) with wide local excision (WLE)
        and sentinel lymph node biopsy (SNB) and/ or complete lymph node dissection in the axilla
        and/or groin will be included in the study.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  AJCC stage IB-III cutaneous melanoma patients

          -  At least one year follow-up after melanoma surgery

        Exclusion Criteria:

          -  Pregnancy

          -  Bilateral axilla or groin melanoma surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Caroline Asirvatham Gjørup, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Plastic Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Plastic Surgery, Herlev Hospital</name>
      <address>
        <city>Herlev</city>
        <zip>1815</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 19, 2015</study_first_submitted>
  <study_first_submitted_qc>January 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2015</study_first_posted>
  <last_update_submitted>May 25, 2016</last_update_submitted>
  <last_update_submitted_qc>May 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Herlev Hospital</investigator_affiliation>
    <investigator_full_name>caroline gjørup</investigator_full_name>
    <investigator_title>M.D. ph.d. student</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melanoma</mesh_term>
    <mesh_term>Lymphedema</mesh_term>
    <mesh_term>Cicatrix</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

